1. Market Research
  2. > Oncology Market Trends
  3. > Cancer Immunotherapy Industry
24/7 Customer Support

Talk to Sam

+1 718 473 0872

Cancer Immunotherapy Industry Statistics

You might be interested in: Therapy, Cancer, Vaccine, Cell Therapy, Pharmaceutical, Chemotherapy, Targeted Therapy, Oncology.

1-7 of 12 reports for Cancer Immunotherapy

Therapy Market and Cancer Immunotherapy Market in the US

  • March 2016
    9 pages
  • Therapy  

    Cancer Immunoth...  

    Chemotherapy  

  • United States  

View report >

Cancer Immunotherapy and Chemotherapy Market in the UK

  • April 2016
    54 pages
  • Cancer Immunoth...  

    Chemotherapy  

  • United Kingdom  

View report >

Cancer Immunotherapy and Chemotherapy Market in Canada

  • April 2016
    85 pages
  • Cancer Immunoth...  

    Chemotherapy  

  • Canada  

View report >

Cancer Immunotherapy Market in Europe

  • April 2014
    9 pages
  • Cancer Immunoth...  

    Cancer  

  • Europe  

View report >

Cancer Immunotherapy Market in Japan

  • June 2014
    56 pages
  • Cancer Immunoth...  

  • Japan  

View report >

Cancer Immunotherapy Market and Therapy Market in the US

  • January 2015
    4 pages
  • Cancer Immunoth...  

    Therapy  

    Healthcare  

  • United States  

View report >

Therapy Market and Cancer Immunotherapy Market in the UK

  • June 2016
    12 pages
  • Therapy  

    Cancer Immunoth...  

    Chemotherapy  

  • United Kingdom  

    United States  

View report >
14 reports for Cancer Immunotherapy

Purchase Reports From Reputable Market Research Publishers
(From $ 1 181 - $ 8 744)

Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics

Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics

  • $ 4 995
  • Industry report
  • June 2016
  • by GBI Research

Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics Summary Urological cancers are thought to account ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.